After more than four decades of leadership by founder Alan Miller, Universal Health Services is preparing for a generational transition that emphasizes continuity alongside strategic evolution. Marc D. Miller, current president and son of the founder, will assume the CEO role in January 2021, taking the helm of one of the nation’s largest behavioral health hospital management organizations with 330 facilities across two continents.
In an exclusive conversation with Behavioral Health Business, the incoming CEO outlined priorities that balance maintaining UHS’s financial stability and culture with expanding outpatient services, advancing telehealth capabilities, and leveraging artificial intelligence to improve clinical outcomes. The transition comes as UHS navigates COVID-19’s ongoing impact on patient volumes while positioning for growth in a behavioral health market experiencing surging demand.
For an industry watching how large hospital systems adapt to shifting care delivery models and technology disruption, UHS’s strategic direction under new leadership offers insights into how established players are evolving beyond traditional inpatient models toward more diverse, digitally-enabled service portfolios.
A Family Business at Fortune 500 Scale
The father-to-son CEO transition at a publicly traded company with billions in revenue might seem unusual in corporate America, but Marc Miller emphasized that continuity represents UHS’s greatest strength during the leadership change.
“Continuity is probably the biggest thing,” Miller explained. “We are a large publicly traded company, and we act like it. But there are certain nuances to our company that are a little bit different.”
Those nuances include a culture that Miller believes differentiates UHS from other large publicly traded healthcare companies. Employee tenure—both at corporate headquarters and in field operations—runs longer than industry norms, suggesting the culture resonates with staff in ways that support retention amid the broader behavioral health workforce crisis.
“People like working at UHS, and one of the ways that we know that is just by the long tenures of so many of our folks,” Miller noted.
The twelve years Miller has already spent as president means the operational transition should be smooth. “There’s not that much that’s going to change as far as the daily operations,” he said, indicating that strategic direction and management approach will remain largely consistent with the path established under his father’s leadership.
This continuity focus makes strategic sense for a company that has successfully grown from a startup in 1979 to a major healthcare system. Dramatic strategic pivots during CEO transitions often create organizational disruption and uncertainty. For UHS, the internal succession allows preservation of institutional knowledge and relationships while providing fresh perspective from a leader who has been intimately involved in operations for over a decade.
COVID’s Persistent Impact on Patient Volumes
Like behavioral health providers across the industry, UHS continues experiencing COVID-19’s effects on patient volumes. In the third quarter of 2020, admissions at behavioral health facilities decreased 5.6% year-over-year on a same-facility basis, while adjusted patient days declined 3.6% compared to Q3 2019.
These declines, while concerning, are less severe than the dramatic drops many providers experienced during early pandemic months. The gradual recovery reflects both patients becoming more comfortable seeking care and facilities implementing safety protocols that reassure patients and families.
However, certain service lines have struggled more than others. Residential treatment centers, in particular, have seen sustained softness that Miller directly attributed to school closures. “A lot of schools have not been back in person since March. Because of that, we’ve seen a softness in the referral patterns that we usually get from those schools,” Miller explained.
For residential treatment centers serving adolescents, schools represent a major referral source. Teachers, counselors, and administrators identify students struggling with behavioral health challenges and connect families with treatment resources. When students aren’t physically attending school, these identification and referral mechanisms break down.
Miller acknowledged that schools account for “a good chunk” of residential treatment center referrals, making them “certainly a main factor” in current volume challenges. He anticipates this will normalize once students return to in-person learning, but timing remains uncertain given ongoing COVID surges in many communities.
The expectation of continued softness “until we get past this totally” reflects realistic assessment of ongoing pandemic disruption. However, Miller expressed encouragement that “so much of our business has started to return,” suggesting the worst volume impacts may be behind the company even if full recovery remains incomplete.
The Outpatient Expansion Imperative
When asked about priorities for 2021, Miller immediately emphasized expanding outpatient services as central to UHS’s growth strategy. “While inpatient remains an important part of our business, our offerings in the outpatient settings continue to increase. We are offering more outpatient alternatives in more markets, and more different types of programming.”
This strategic direction aligns with broader industry trends toward lower-intensity, community-based care. Inpatient psychiatric hospitalization remains essential for acute crises, but most people with behavioral health conditions benefit more from outpatient services that allow them to remain in their communities, maintain jobs and relationships, and access care on an ongoing basis rather than just during crises.
For UHS, outpatient expansion also addresses market dynamics. Demand for behavioral health services is surging while inpatient capacity growth faces regulatory, capital, and community resistance constraints. Outpatient services can scale more flexibly through new clinic locations, expanded hours, and additional staff without the enormous capital investment and regulatory approval required for new inpatient facilities.
Miller noted that increasing outpatient offerings has been a long-term priority “for a long time but certainly are trying to do now,” suggesting the pandemic has accelerated existing strategic direction rather than creating entirely new priorities. The intensified mental health crisis and demonstrated viability of alternative care delivery models during COVID-19 have reinforced the business case for outpatient expansion.
The company is “working on new things for 2021,” Miller teased, without providing specifics about what new outpatient programming might include. Possibilities could range from intensive outpatient programs and partial hospitalization to specialized programming for specific populations or conditions, or integration of services addressing co-occurring disorders.
Telehealth Expansion and Reimbursement Uncertainty
Alongside outpatient expansion, telehealth represents another major growth area for UHS. Miller emphasized that “teleservices” have existed at UHS for years, but the company is “continuing to try to perfect those services and increase offerings in that area.”
The careful phrasing around “perfecting” telehealth services acknowledges that simply offering virtual visits doesn’t guarantee clinical effectiveness or operational efficiency. Making telehealth work well requires technology infrastructure, clinical workflows adapted for virtual delivery, staff training, and patient engagement strategies different from in-person care.
UHS’s approach appears to be iterative refinement rather than wholesale reinvention—building on existing telehealth capabilities while expanding scope and improving quality. This measured approach contrasts with providers who rushed into telehealth during COVID-19 without prior experience and are still working through operational challenges.
However, Miller identified a critical uncertainty around telehealth sustainability: reimbursement. “If the federal government and insurers continue to reimburse for teleservices, as they have during the pandemic, that’s going to be a benefit to patients who now have another way to access care.”
Before COVID-19, many insurance companies either didn’t cover telehealth for behavioral health or reimbursed at rates providers found inadequate. Pandemic-era regulatory waivers and expanded coverage made telehealth financially viable, driving explosive adoption. But those temporary policies will eventually expire unless made permanent through legislation or regulation.
Miller’s comment that pre-pandemic, insurers “were not covering them at a rate that was acceptable to providers” highlights the economic reality underlying telehealth adoption. Providers can deliver excellent virtual care, but if reimbursement doesn’t cover costs, those services can’t be sustained except as loss leaders to support other business lines.
For UHS, permanent telehealth reimbursement at reasonable rates would “increase access for patients” while supporting business growth. Without it, the company may need to scale back virtual services or limit them to commercially insured populations while reducing availability for Medicaid and uninsured patients.
Joint Ventures With Health Systems Continue
UHS has pursued joint ventures with large nonprofit health systems as a growth strategy, and Miller indicated those plans remain on track despite pandemic disruptions. “Our planned JVs thus far have not been affected. We have a number of JVs that are being rolled out right now with some of the largest not-for-profit healthcare systems in the country.”
The joint venture model offers mutual benefits. Nonprofit health systems gain behavioral health expertise and operational capabilities they often lack internally, while UHS gains access to established patient populations, referral networks, and market presence. For health systems recognizing that behavioral health is essential to population health management and value-based care success, partnering with specialized operators like UHS provides faster entry than building programs from scratch.
Miller expressed excitement about “our ability to partner with some of these great health systems to assist where we can on the behavioral side—bringing our knowledge base, then also learning from them about their markets to affect positive change for patient care.”
This framing emphasizes mutual learning rather than UHS simply providing services to health system partners. Understanding local market dynamics, community needs, and health system culture all influence program success. The best joint ventures leverage both parties’ strengths rather than one partner dictating approach.
UHS continues discussing new joint venture opportunities with health systems, though Miller acknowledged being “not sure if any of those systems have slowed down their timetables” due to COVID-19. The fact that discussions continue and planned joint ventures are launching suggests health systems view behavioral health as strategic priorities worth pursuing despite pandemic-related financial pressures.
Measured Growth Philosophy
When asked about specific growth targets, Miller declined to provide numerical goals, explaining UHS’s philosophy: “We are a growth company, and we always have been. We continue to work on our development opportunities, like we always have, and we seem to be able to grow at a good rate by doing so. But we never want to say that we’re looking to add a certain number of deals or a certain amount of revenue. We don’t want to force ourselves into anything.”
This measured approach contrasts with some private equity-backed behavioral health platforms that pursue aggressive growth with specific facility count or revenue targets. UHS’s philosophy emphasizes opportunistic growth—pursuing deals that “make sense” rather than forcing acquisitions to hit predetermined numbers.
For a publicly traded company, this creates tension with investor expectations around growth predictability and forward guidance. However, UHS’s 41-year track record of growth without forced acquisitions supports the discipline of pursuing quality opportunities rather than quantity of deals.
The approach also reflects UHS’s financial strength. Miller emphasized early in the conversation that “we’re a financially healthy company. We spend a lot of time trying to ensure that we have a healthy balance sheet and that we’re going to be able to remain healthy so that we can provide services well into the future.”
Companies with strong balance sheets and operational cash flow can afford to be patient and selective. They don’t need to force growth to satisfy debt covenants or investor return requirements within specific timeframes. This financial position provides competitive advantage in evaluating opportunities without time pressure.
Innovation Through AI and Technology Partnerships
Beyond traditional expansion, UHS is investing in innovation through its internal Innovation Hub and partnerships with technology companies. The most specific example Miller discussed involves Eleos Health, an artificial intelligence platform pilot launched through the Innovation Hub.
“Eleos has decision support software that is going to allow us to analyze voice and speech patterns from patients during therapy sessions. That hopefully will let us care better for the patients and learn different things than we would without it, to ultimately produce better outcomes.”
This application of AI to behavioral health treatment represents cutting-edge work. Voice and speech pattern analysis during therapy could identify clinical indicators invisible to human observation—subtle changes in affect, speech rhythm, or vocabulary that correlate with symptom severity or treatment response. These insights could help clinicians adjust treatment approaches, identify patients at risk for crisis, or predict which interventions will be most effective for specific individuals.
The technology also could improve documentation and clinical decision support. Therapy sessions generate enormous amounts of qualitative data that’s difficult to analyze systematically. AI that extracts patterns and insights from therapy conversations could help clinicians work more efficiently while improving care quality.
UHS is “continuing our pilots with Eleos, and we hope to have something to move forward on very soon,” Miller said, suggesting initial results are promising enough to consider broader implementation.
Beyond Eleos, Miller indicated UHS has “a number of partnerships we’re working on in the AI space—and on other technological advances—to help us clinically in the behavioral health space.” The company expects to “sign a few more partnerships” in 2021 to “advance the ability to care for patients in a way that we aren’t able to do without these types of ventures.”
This innovation focus signals that UHS doesn’t view itself as just a traditional hospital operator but as an organization embracing technology to improve clinical care. For a company often associated with inpatient facilities, the emphasis on AI, telehealth, and digital innovation suggests strategic recognition that future competitive advantage requires technological sophistication alongside operational excellence.
The Cyber Attack Response and Lessons
UHS experienced a significant cyber attack in late September 2020 that received substantial media coverage. Miller addressed the incident directly, describing both the immediate response and lessons learned.
“Our company spends a lot of money, time and effort on cyber security. We thought we were as well protected as any other health care company in the industry, and yet, we still got hit.”
This acknowledgment reflects the reality that even well-prepared healthcare organizations face cyber threats that can succeed despite substantial security investments. The healthcare industry has become a prime target for ransomware and other attacks because patient care criticality creates pressure to pay ransoms and because healthcare organizations often have valuable personal health information.
However, Miller emphasized that UHS’s preparation allowed “better” outcomes than some healthcare organizations have experienced with similar attacks: “We didn’t lose any data. No personal information was compromised. We were able to get back up and running ourselves, just working with our own cyber team internally and a couple of external partners.”
The key to this relatively successful response was early detection and immediate action. “We were alerted to the problem almost immediately, so we shut down our systems right when those alerts came in. By doing so, none of our equipment was compromised.”
This rapid shutdown prevented the attack from spreading to medical equipment, though it did require reimaging all PCs—a time-consuming but manageable remediation task. The ability to safely restore systems without paying ransoms or suffering data loss represents a security program working as designed during an actual attack.
UHS continues conducting forensic audits and plans to “make some corrections, and just try to revamp and increase what I thought was and I still believe was a pretty good security apparatus. But you can always learn and always do a little bit better.”
For other healthcare organizations, UHS’s experience offers lessons about the value of robust monitoring, incident response plans that enable rapid action, and the importance of system architecture that contains breaches rather than allowing attackers to compromise entire networks.
Challenges on the Horizon
When asked about anticipated challenges, Miller identified three primary concerns: staffing, COVID-19’s ongoing impact, and reimbursement uncertainty.
Staffing challenges vary by market but represent persistent concerns across UHS’s portfolio. “The advantage of UHS is that we’ve got a great reputation nationally, as well as in our markets, so that helps us on the staffing side,” Miller noted, suggesting brand strength and organizational reputation provide competitive advantages in workforce recruitment.
However, no healthcare organization is immune to the broader behavioral health workforce shortage. Competition for psychiatrists, psychologists, therapists, nurses, and other clinical staff remains intense. UHS’s size and resources help but don’t eliminate workforce constraints that limit growth and require ongoing attention to compensation, culture, and career development.
COVID-19’s trajectory remains uncertain, particularly regarding when schools will fully return to in-person learning and restore normal referral patterns for adolescent services. Until pandemic impacts fully resolve, volume uncertainty will persist.
Reimbursement policy, particularly around telehealth, creates strategic uncertainty. UHS is investing in telehealth expansion, but sustainability depends on payers maintaining coverage and adequate reimbursement rates. Advocating for permanent telehealth payment parity will likely remain a priority for UHS and the broader industry.
What the Transition Signals
Marc Miller’s ascension to CEO represents more than just family succession. His priorities—outpatient expansion, telehealth growth, AI innovation, and joint ventures with health systems—reflect strategic evolution for UHS beyond its historical identity as primarily an inpatient hospital operator.
The emphasis on continuity and financial stability suggests UHS won’t pursue dramatic transformation or risky pivots. Instead, the approach appears to be measured evolution: expanding service lines, embracing technology, and partnering strategically while maintaining the financial strength and operational excellence that have driven four decades of growth.
For the behavioral health industry, UHS’s direction offers a template for how large, established providers might adapt to changing market dynamics without abandoning core competencies. The strategy combines inpatient excellence with outpatient expansion, traditional facilities with telehealth innovation, and organic growth with partnership models.
As Miller concluded the conversation, he reiterated the continuity theme: “We’re excited about the CEO transition, but we knew that this transition would happen at some point. We expect to continue on the same path that we’ve been on and hopefully continue with our success.”
That path—stable, measured, incrementally innovative—may lack the excitement of dramatic disruption, but for a company managing 330 behavioral health facilities serving vulnerable populations, stability paired with strategic evolution may be exactly the right approach for sustainable long-term success.
